Lumingkit, Baby Girl .
HRN: 28-66-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2026
AMPICILLIN 250MG (VIAL)
03/13/2026
03/20/2026
IV
125mg
Q12
Neonatal Sepsis
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: